447 related articles for article (PubMed ID: 11716066)
21. Molecular targeting for malignant gliomas (Review).
Kondo Y; Hollingsworth EF; Kondo S
Int J Oncol; 2004 May; 24(5):1101-9. PubMed ID: 15067331
[TBL] [Abstract][Full Text] [Related]
22. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain.
Furnari FB; Lin H; Huang HS; Cavenee WK
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12479-84. PubMed ID: 9356475
[TBL] [Abstract][Full Text] [Related]
23. Adhesion molecules and the extracellular matrix as drug targets for glioma.
Shimizu T; Kurozumi K; Ishida J; Ichikawa T; Date I
Brain Tumor Pathol; 2016 Apr; 33(2):97-106. PubMed ID: 26992378
[TBL] [Abstract][Full Text] [Related]
24. Molecular abnormalities and correlations with tumor response and outcome in glioma patients.
Pollack IF; Hamilton RL; Finkelstein SD; Lieberman F
Neuroimaging Clin N Am; 2002 Nov; 12(4):627-39. PubMed ID: 12687916
[TBL] [Abstract][Full Text] [Related]
25. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
26. Signaling Determinants of Glioma Cell Invasion.
Kwiatkowska A; Symons M
Adv Exp Med Biol; 2020; 1202():129-149. PubMed ID: 32034712
[TBL] [Abstract][Full Text] [Related]
27. Oncogenes: cause or consequence in the development of glial tumors.
Akbasak A; Sunar-Akbasak B
J Neurol Sci; 1992 Sep; 111(2):119-33. PubMed ID: 1331337
[TBL] [Abstract][Full Text] [Related]
28. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.
Davies MP; Gibbs FE; Halliwell N; Joyce KA; Roebuck MM; Rossi ML; Salisbury J; Sibson DR; Tacconi L; Walker C
Br J Cancer; 1999 Mar; 79(9-10):1542-8. PubMed ID: 10188904
[TBL] [Abstract][Full Text] [Related]
29. ECM-mediated glioma cell invasion.
Goldbrunner RH; Bernstein JJ; Tonn JC
Microsc Res Tech; 1998 Nov; 43(3):250-7. PubMed ID: 9840803
[TBL] [Abstract][Full Text] [Related]
30. Brain tumor cell invasion, anatomical and biological considerations.
Thorsen F; Tysnes BB
Anticancer Res; 1997; 17(6B):4121-6. PubMed ID: 9428345
[TBL] [Abstract][Full Text] [Related]
31. [Genes implicated in glial tumors].
Sanson M; Marie Y; Huguet S; He J; Hoang-Xuan K
Morphologie; 2000 Jun; 84(265):51-5. PubMed ID: 11048299
[TBL] [Abstract][Full Text] [Related]
32. miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.
Peng G; Liao Y; Shen C
Pathol Oncol Res; 2017 Apr; 23(2):369-376. PubMed ID: 27663885
[TBL] [Abstract][Full Text] [Related]
33. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
Furukawa K; Kumon Y; Harada H; Kohno S; Nagato S; Teraoka M; Fujiwara S; Nakagawa K; Hamada K; Ohnishi T
Int J Oncol; 2006 Jul; 29(1):73-81. PubMed ID: 16773187
[TBL] [Abstract][Full Text] [Related]
34. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
35. Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition.
Rajesh Y; Biswas A; Mandal M
Exp Cell Res; 2017 Oct; 359(2):299-311. PubMed ID: 28844885
[TBL] [Abstract][Full Text] [Related]
36. Integrins: molecular determinants of glioma invasion.
D'Abaco GM; Kaye AH
J Clin Neurosci; 2007 Nov; 14(11):1041-8. PubMed ID: 17954373
[TBL] [Abstract][Full Text] [Related]
37. Genetics of brain neoplasms.
Shapiro JR
Curr Neurol Neurosci Rep; 2001 May; 1(3):217-24. PubMed ID: 11898521
[TBL] [Abstract][Full Text] [Related]
38. Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN.
Koul D; Parthasarathy R; Shen R; Davies MA; Jasser SA; Chintala SK; Rao JS; Sun Y; Benvenisite EN; Liu TJ; Yung WK
Oncogene; 2001 Oct; 20(46):6669-78. PubMed ID: 11709701
[TBL] [Abstract][Full Text] [Related]
39. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
40. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
